Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly

References

• Burki T. WHO ends the COVID-19 public health emergency. Lancet Respir Med. 2023;11(7):588. doi:10.1016/S2213-2600(23)00217-5.
   PubMed Web of Science ®Google Scholar
• Yi WW. COVID-19 deaths hit record high in Korea for 2022. The Korea Times [Internet]; 2023 Sep 22 [acessed 2023 Dec 30]. https://www.koreatimes.co.kr/www/biz/2024/01/602_359771.html.
   Google Scholar
• Kwon SL, Kim BI. How COVID‐19 shifted the seasonal flu in Korea. Influenza Other Respir Viruses. 2023;17(3). doi:10.1111/irv.13113.
   PubMed Web of Science ®Google Scholar
• Cha J, Seo Y, Kang S, Kim I, Gwack J. Sentinel surveillance results for influenza and acute respiratory infections during the coronavirus disease 2019 pandemic. Public Health Wkly Rep. 2023;16(20):597–8. doi:10.56786/phwr.2023.16.20.1.
   Google Scholar
• Hwang JH, Lee JH, Jang EJ, Kim RK, Lee KH, Park SK, Lee SE, Chae C, Lee S, Park YJ, et al. Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea. Osong Public Health Res Perspect. 2023;14(3):164–72. doi:10.24171/j.phrp.2023.0096.
   PubMedGoogle Scholar
• Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Health. 2021;9:698111. doi:10.3389/fpubh.2021.698111.
   PubMed Web of Science ®Google Scholar
• Shenyu W, Xiaoqian D, Bo C, Xuan D, Zeng W, Hangjie Z, Qianhui Z, Zhenzhen L, Chuanfu Y, Juan Y, et al. Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: a randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China. Vaccine. 2022;40(36):5356–65. doi:10.1016/j.vaccine.2022.07.021.
   PubMed Web of Science ®Google Scholar
• Xie Y, Tian X, Zhang X, Yao H, Wu N. Immune interference in effectiveness of influenza and COVID-19 vaccination. Front Immunol. 2023;14. doi:10.3389/fimmu.2023.1167214.
   Web of Science ®Google Scholar
• Murdoch L, Quan K, Baber JA, Ho AWY, Zhang Y, Xu X, Lu C, Cooper D, Koury K, Lockhart SP, et al. Safety and immunogenicity of the BNT162b2 vaccine coadministered with seasonal inactivated influenza vaccine in adults. Infect Dis Ther. 2023;12(9):2241–58. doi:10.1007/s40121-023-00863-5.
   PubMed Web of Science ®Google Scholar
• Liu C. Economic evaluation of covid-19 vaccines: a literature review. Highlights Bus Econ Manage. 2023;3:197–203. doi:10.54097/hbem.v3i.4737.
   Google Scholar
• Moss S, Jurkowicz M, Nemet I, Atari N, Kliker L, Abd-Elkader B, Gonen T, Martin ET, Lustig Y, Regev-Yochay G, et al. Immunogenicity of co-administered omicron BA.4/BA.5 bivalent COVID-19 and quadrivalent seasonal influenza vaccines in Israel during the 2022–2023 Winter season. Nato Adv Sci Inst Se. 2023;11(10):1624. doi:10.3390/vaccines11101624.
   Google Scholar
• Wang G, Yao Y, Wang Y, Gong J, Meng Q, Wang H, Wang W, Chen X, Zhao, Y. COVID‐19 vaccine hesitancy of older people in China. Clin Transl Med. 2023;13(9). doi:10.1002/ctm2.1397.
   Web of Science ®Google Scholar
• Capodici A, Montalti M, Soldà G, Salussolia A, La Fauci G, Di Valerio Z, Scognamiglio F, Fantini MP, Odone A, Costantino C, et al. Influenza vaccination landscape in Italy: a comprehensive study through the OBVIOUS project lens. Hum Vaccin Immunother. 2023;19(2):2252250. doi:10.1080/21645515.2023.2252250.
   PubMed Web of Science ®Google Scholar
• Seo-Hyeon Ahn SLK, Song M-J, Jeon S-S, Lee J-Y, Park J-H, Bae H-A, Lee J-E, Lee H-M. The Republic of Korea national influenza vaccination project: outcomes of the 2022–2023 season. Public Health Wkly Rep. 2023;16(40):1354–66. doi:10.56786/phwr.2023.16.40.2.
   Google Scholar
• Garza N, Leibensperger M, Bonnevie E. The association between receiving the flu and COVID-19 vaccines and related factors, data from the StopFlu campaign in Eight States and the District of Columbia, 2022. J Community Health. 2023;48(4):731–9. doi:10.1007/s10900-023-01213-9.
   PubMed Web of Science ®Google Scholar
• Zampetakis LA, Melas C. The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach. Appl Psychol Health Well Being. 2021;13(2):469–84. Epub 20210226. doi:10.1111/aphw.12262.
   PubMed Web of Science ®Google Scholar
• Thomas S, Ouhtit A, Al Khatib HA, Eid AH, Mathew S, Nasrallah GK, Emara MM, Al Maslamani MA, Yassine HM. Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients. J Infect Public Health. 2022;15(4):412–24. doi:10.1016/j.jiph.2022.03.002.
   PubMed Web of Science ®Google Scholar
• Troeger CE, Blacker BF, Khalil IA, Zimsen SR, Albertson SB, Abate D, Abdela J, Adhikari TB, Aghayan SA, Agrawal S, et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the global burden of disease study 2017. Lancet Respir Med. 2019;7(1):69–89. doi:10.1016/S2213-2600(18)30496-X.
   PubMed Web of Science ®Google Scholar
• Kim JH, Song MJ, Ahn SH, Kwon SL. Twenty years of progress and the way forward: immunization registry information system in Korea. J Korean Med Sci. 2024;39(12):e119. doi:10.3346/jkms.2024.39.e119.
   PubMed Web of Science ®Google Scholar
• Shmueli L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health. 2021;21:1–13. doi:10.1186/s12889-021-10816-7.
   PubMed Web of Science ®Google Scholar
• Limbu YB, Gautam RK, Pham L. The health belief model applied to COVID-19 vaccine hesitancy: a systematic review. Vaccines. 2022;10(6):973. Epub 20220618. doi:10.3390/vaccines10060973.
   Web of Science ®Google Scholar
• Didierlaurent AM, Lambert P-H. Co-administration of COVID-19 and influenza vaccines. Clin Microbiol Infect. 2023;29(5):558–9. doi:10.1016/j.cmi.2023.02.003.
   PubMed Web of Science ®Google Scholar
• Reses HE, Dubendris H, Haas L, Barbre K, Ananth S, Rowe T, Mothershed E, Hall E, Wiegand RE, Lindley MC. Coverage with influenza, respiratory syncytial virus, and updated COVID-19 vaccines among nursing home residents—National Healthcare Safety Network, United States, December 2023. MMWR Morb Mortal Wkly Rep. 2023;72(51):1371–6. doi:10.15585/mmwr.mm7251a3.
   PubMed Web of Science ®Google Scholar
• Black CL, Kriss JL, Razzaghi H, Patel SA, Santibanez TA, Meghani M, Tippins A, Stokley S, Chatham-Stephens K, Dowling NF. Influenza, updated COVID-19, and respiratory syncytial virus vaccination coverage among adults—United States, fall 2023. MMWR Morb Mortal Wkly Rep. 2023;72(51):1377–82. doi:10.15585/mmwr.mm7251a4.
   PubMed Web of Science ®Google Scholar
• Pascucci D, Lontano A, Regazzi L, Marziali E, Nurchis MC, Raponi M, Vetrugno G, Moscato U, Cadeddu C, Laurenti P, et al. Co-administration of SARS-CoV-2 and influenza vaccines in healthcare workers: results of two vaccination campaigns in a large teaching hospital in Rome. Hum Vaccin Immunother. 2023;19(3):2287282. doi:10.1080/21645515.2023.2287282. Epub 20231128.
   PubMed Web of Science ®Google Scholar
• Domnich A, Orsi A, Trombetta CS, Guarona G, Panatto D, Icardi G. COVID-19 and seasonal influenza vaccination: cross-protection, Co-administration, combination vaccines, and hesitancy. Pharmaceuticals (Basel). 2022;15(3):322. doi:10.3390/ph15030322. Epub 20220308.
   PubMedGoogle Scholar
• Yenew C, Dessie AM, Gebeyehu AA, Genet A. Intention to receive COVID-19 vaccine and its health belief model (HBM)-based predictors: a systematic review and meta-analysis. Hum Vaccin Immunother. 2023;19(1):2207442. doi:10.1080/21645515.2023.2207442. Epub 20230512.
   PubMed Web of Science ®Google Scholar
• Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr. 1974;2(4):328–35. doi:10.1177/109019817400200403.
   Google Scholar
• Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother. 2022;18(1):1950504. doi:10.1080/21645515.2021.1950504. Epub 20210730.
   PubMed Web of Science ®Google Scholar
• Bolsewicz KT, Steffens MS, King C, Abdi I, Bullivant B, Beard F. A qualitative study on COVID-19 pandemic impacts on parental attitudes and intentions for routine adolescent vaccinations: the role of trust. Vaccine. 2023;41(28):4138–43. doi:10.1016/j.vaccine.2023.05.037. Epub 20230522.
   PubMed Web of Science ®Google Scholar
• Stefanizzi P, Tafuri S, Bianchi FP. Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: an open question. Hum Vaccin Immunother. 2022;18(6). doi:10.1080/21645515.2022.2094653.
   Web of Science ®Google Scholar
• Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(2):167–79. doi:10.1016/s2213-2600(21)00409-4.
   PubMed Web of Science ®Google Scholar
• Choi Y, Park S, Lee J, Kim Y, Kim BJ, Lin L, Fox AM. Who gets COVID-19 booster vaccination? Trust in public health institutions and promotion strategies post-pandemic in the Republic of Korea. Vaccine. 2023;41(50):7560–72. doi:10.1016/j.vaccine.2023.11.001.
   PubMed Web of Science ®Google Scholar
• Hause AM, Zhang B, Yue X, Marquez P, Myers TR, Parker C, Gee J, Su J, Shimabukuro TT, Shay DK, et al. Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Netw Open. 2022;5(7):e2222241. doi:10.1001/jamanetworkopen.2022.22241.
   PubMed Web of Science ®Google Scholar
• Cho HK, Lee H, Choe YJ, Kim S, Seo S, Moon J, Choi EH, Kwon G-Y, Shin JY, Choi S-Y, et al. Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication. Epidemiol Health. 2022;45:e2023004. doi:10.4178/epih.e2023004. Epub 20221213.
   PubMed Web of Science ®Google Scholar
• Coman IA, Xu S, Yamamoto M. COVID-19 vaccine hesitancy: disadvantaged groups’ experience with perceived barriers, cues to action, and attitudes. Am J Health Promot. 2023;37(4):488–98. doi:10.1177/08901171221136113.
   PubMed Web of Science ®Google Scholar
• Gori D, Capodici A, La Fauci G, Montalti M, Salussolia A, Soldà G, Di Valerio Z, Scognamiglio F, Fantini MP, Leask J, et al. COVID-19 vaccine refusal and delay among adults in Italy: evidence from the OBVIOUS project, a National Survey in Italy. Nato Adv Sci Inst Se. 2023;11(4):839. doi:10.3390/vaccines11040839.
   Google Scholar